Qu Biologics Begins Phase 2 Clinical Trial in Crohn’s Disease
18 avr. 2018 16h16 HE
|
Qu Biologics
VANCOUVER, British Columbia, April 18, 2018 (GLOBE NEWSWIRE) -- Qu Biologics Inc. (Qu), a Vancouver, Canada-based biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique...